Probiotic-based therapy for lowering cholesterol, and triglycerides levels: Lactobacillus fermentum DR9 (LF-DR9) decreases the levels of HMGCR,  triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD), via up-regulation of its target gene, 17/December/2018, 11.55 pm

"Help us make a difference by supporting our mission with your generous donation."

Spread the love


Spread the love
small_c_popup.png

Let's have a chat!

Sign-up for our newsletter to learn more about upcoming Genomediscovery Forums!